Sugarloaf Wealth Management’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$3.05K Hold
44
﹤0.01% 611
2024
Q3
$3.7K Hold
44
﹤0.01% 590
2024
Q2
$2.98K Hold
44
﹤0.01% 563
2024
Q1
$2.77K Hold
44
﹤0.01% 575
2023
Q4
$2.46K Hold
44
﹤0.01% 593
2023
Q3
$2.26K Hold
44
﹤0.01% 595
2023
Q2
$2.31K Hold
44
﹤0.01% 605
2023
Q1
$2.27K Hold
44
﹤0.01% 607
2022
Q4
$2.3K Hold
44
﹤0.01% 662
2022
Q3
$3K Hold
44
﹤0.01% 675
2022
Q2
$3K Hold
44
﹤0.01% 664
2022
Q1
$3K Hold
44
﹤0.01% 617
2021
Q4
$3K Hold
44
﹤0.01% 642
2021
Q3
$2K Hold
44
﹤0.01% 687
2021
Q2
$3K Hold
44
﹤0.01% 648
2021
Q1
$3 Hold
44
﹤0.01% 638
2020
Q4
$3K Hold
44
﹤0.01% 604
2020
Q3
$3K Hold
44
﹤0.01% 581
2020
Q2
$2K Hold
44
﹤0.01% 610
2020
Q1
$2K Hold
44
﹤0.01% 603
2019
Q4
$4K Buy
+44
New +$3.6K ﹤0.01% 573

Other funds holding NHI

Sugarloaf Wealth Management's NHI Position: Q4 2024 in Review

Sugarloaf Wealth Management held its National Health Investors (NHI) position steady in Q4 2024 at 44 shares worth $3.05K. The position accounts for ﹤0.01% of the portfolio, ranked #611.

Sugarloaf Wealth Management first reported a position in NHI in Q4 2019 and has held it in 21 quarters since. The position peaked at $4K in Q4 2019. 277 funds tracked by Wall St. Rank hold NHI as of Q4 2024.

  • Sugarloaf Wealth Management held 44 shares of National Health Investors worth $3.05K as of Q4 2024.
  • Sugarloaf Wealth Management left its National Health Investors share count unchanged in Q4 2024.
  • National Health Investors made up ﹤0.01% of Sugarloaf Wealth Management's portfolio in Q4 2024, its #611 holding.
  • Sugarloaf Wealth Management first reported a position in National Health Investors in Q4 2019 and has held it in 21 quarters since.
  • Sugarloaf Wealth Management's National Health Investors position peaked at $4K in Q4 2019.
  • 277 funds tracked by Wall St. Rank held National Health Investors as of Q4 2024.

Based on Sugarloaf Wealth Management's 13F filing for Q4 2024, filed 10 Jan 2025.